Abstract
Tau proteins play an important role in the proper assembly and function of neurons. Hyperphosphorylation of tau by kinases such as tau tubulin kinase (TTBK) has been hypothesized to cause the aggregation of tau and the formation of neurofibrillary tangles (NFTs) that lead to the destabilization of microtubules, thereby contributing to neurodegenerative diseases such as Alzheimer's disease (AD). There are two TTBK isoforms with highly homologous catalytic sites but with distinct tissue distributions, tau phosphorylation patterns and loss-of-function effects. Inhibition of TTBK1 reduces the levels of NFT formation involved in neurodegenerative diseases such as AD, whereas inhibition of TTBK2 may lead to the movement disorder spinocerebellar ataxia type 11 (SCA11). Hence, it is critical to obtain isoform-selective inhibitors. Structure-based drug design (SBDD) has been used to design highly potent and exquisitely selective inhibitors. While structures of TTBK1 have been reported in the literature, TTBK2 has evaded structural characterization. Here, the first crystal structure of the TTBK2 kinase domain is described. Furthermore, the crystal structure of human TTBK2 in complex with a small-molecule inhibitor has successfully been d...Continue Reading
References
Sep 18, 1995·FEBS Letters·M TakahashiA Omori
Apr 1, 1995·Journal of Neurochemistry·M TakahashiK Imahori
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·A C AlonsoK Iqbal
Dec 1, 1998·Journal of Neurochemistry·D P HangerB H Anderton
Mar 21, 2001·FEBS Letters·K TomizawaM Takahashi
Aug 23, 2006·Journal of Neurochemistry·Shinji SatoTsuneya Ikezu
Jul 11, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Michiko Kitano-TakahashiToshiyuki Kohno
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jun 23, 2009·Journal of Alzheimer's Disease : JAD·Thibaud LebouvierPascal Derkinderen
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Dec 15, 2010·The International Journal of Biochemistry & Cell Biology·Jit Kong Cheong, David M Virshup
Jan 12, 2011·Neuroscience Letters·Nan-Nan YuLan Tan
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Philip R Evans
May 10, 2011·The Biochemical Journal·Michale BouskilaDario R Alessi
Jan 22, 2013·ACS Medicinal Chemistry Letters·Vassilios MyrianthopoulosAlexios-Leandros Skaltsounis
Sep 17, 2013·ChemMedChem·Yafeng XueNiek Dekker
Mar 19, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Susan E KieferSteven Sheriff
May 9, 2014·Frontiers in Molecular Neuroscience·Seiko Ikezu, Tsuneya Ikezu
Dec 6, 2014·Journal of Medicinal Chemistry·R S K VijayanRonald M Levy
Jan 20, 2018·European Journal of Medicinal Chemistry·Frank LoveringChristoph W Zapf
Apr 27, 2019·Frontiers in Pharmacology·Chao ShenXiaojun Yao
Oct 8, 2019·Acta Crystallographica. Section D, Structural Biology·Dorothee LiebschnerPaul D Adams